Ovarian Cancer News

Studies: Pox Vaccines Extend Survival for Patients with Melanoma, Ovarian Cancer
Monday, March 26, 2012

BUFFALO, NY — An immunotherapy regimen incorporating poxviruses and targeting a particular tumor antigen, NY-ESO-1, has shown promise in treating two types of cancers.

Roswell Park Launches Landmark Immunotherapy Vaccine Trial
Tuesday, January 24, 2012

PLEASE NOTE: As expected, Roswell Park Cancer Institute continues to receive a very high volume of calls and emails from patients and their families regarding the vaccine clinical research study...

Media Advisory: New Investigational Cancer Vaccine to be Announced by RPCI at Press Conference Tuesday
Friday, January 20, 2012

WHAT:    International press conference announcing development of an investigational vaccine, to be produced through a process available only at Roswell Park Cancer Institute (RPCI),...

Roswell Park Cancer Institute Researcher to Study Familial Ovarian Cancer Risk Factors
Wednesday, April 21, 2010

BUFFALO, NY: Roswell Park Cancer Institute (RPCI) has been awarded a grant of $200,000 by the Ralph Wilson Medical Research Foundation to...

Hot Off Fashion Week, Noted Designer Adam Lippes to Appear at Buffalo Benefit in Mother’s Memory
Tuesday, September 22, 2009

BUFFALO, NY - Adam Lippes, famed New York City designer known for the wild success of his ADAM collection, will make a rare appearance, returning to his Buffalo roots, on Thursday, October 1 to celebrate his...

Roswell Park Awarded $2.8 Million Grant to Study Ovarian Cancer
Wednesday, July 22, 2009

BUFFALO, NY – The National Cancer Institute has awarded a five-year, $2.8 million Research Project (RO1) grant to Roswell Park Cancer Institute (RPCI) researchers to investigate the role of immunological...